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AbstrACt
Introduction Cauda equina syndrome (CES) is a serious 
neurological condition most commonly due to compression 
of the lumbosacral nerve roots, which can result in 
significant disability. The evidence for acute intervention 
in CES is mainly from retrospective studies. There is 
heterogeneity in the outcomes chosen for analysis in these 
studies, which makes it difficult to synthesise the data 
across studies. This study will develop a core outcome 
set for use in future studies of CES, engaging with key 
stakeholders and using transparent methodology. This will 
help ensure that relevant outcomes are used in future and 
will facilitate attempts to summarise data across studies in 
systematic reviews.
Methods and analysis A systematic literature review 
will document all the outcomes for CES after surgery 
mentioned in the literature. The qualitative interviews with 
patients with CES will be semistructured, audio recorded, 
transcribed and thematically analysed with the use of 
NVivo V.10 to identify outcomes and determine the themes 
described. The outcomes from the literature review and 
patient interviews will be combined and prioritised to 
determine what the most important outcomes are in CES 
research studies to patients and healthcare professionals. 
The prioritisation will be done through a two-round 
iterative Delphi survey and a consensus meeting. This 
process will decide the core outcome set for patients with 
CES.
Ethics and dissemination REC and HRA approval was 
obtained on the 6/12/16 for the qualitative interviews 
from South Central—Hampshire A REC. REC reference 16/
SC/0587. REC and HRA approval was obtained on 26/3/18 
for the Delphi process and consensus meeting from North 
West—Greater Manchester Central REC. REC reference 
was 18/NW/0022. The final core outcome set will be 
published and freely available.
trial registration number This study is registered 
with the Core Outcome Measures in Effectiveness Trials 
database as study 824.
IntroduCtIon  
Cauda equina syndrome (CES) is due to 
dysfunction of the lumbosacral nerve roots 
beneath the conus medullaris resulting in 
sensorimotor deficits of the lower limbs and 
sphincter dysfunction. Symptoms and signs 
include low back pain, unilateral or bilat-
eral sciatica, saddle anaesthesia and motor 
weakness of the lower extremities with 
bladder and/or bowel dysfunction.1 2 The 
most common cause of CES is a herniated 
lumbar disc, and represents 2% of all herni-
ated lumbar discs. CES has an incidence of 2 
per 100 000 in England and is an indication 
for emergency decompression surgery.3–5 
Other less common aetiologies include spinal 
stenosis, spinal tumours, haematomas, frac-
tures and infections.2 The National Spinal 
Task Force showed that there are 981 opera-
tions done each year for CES in the UK from 
2010 to 2011.6 Surgical intervention for CES 
is not a rare procedure, and the economic 
burden of severe disability is a worrying 
strengths and limitations of this study
 ► A systematic literature review following Preferred 
Reporting Items for Systematic Reviews and Meta-
Analyses guidelines will identify outcomes in the 
existing literature for cauda equina syndrome (CES).
 ► Semistructured qualitative interviews using a sam-
pling frame to select a varied sample of patients 
with CES will identify outcomes important to them.
 ► The consensus process of an international online 
Delphi survey and an international face to face con-
sensus meeting will involve patients and healthcare 
professionals.
 ► A core outcome set will allow future CES research 
studies to use outcomes relevant to key stakehold-
ers and allow synthesis of data in CES.
 ► The outcomes that constitute the core outcome set 
will be reported. ‘How’ these outcomes are mea-
sured will not be determined in this study and re-
quires further work.
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unknown for both patient quality of life and development 
of appropriate health services.
The evidence for acute intervention in CES is mainly 
from retrospective studies.7 8 The importance of cate-
gorising CES into CES incomplete (CESI) and CES 
complete with urinary retention (CESR) has been high-
lighted in the literature.4 CESR describes painless urinary 
retention with overflow incontinence and complete 
perianal sensory loss. When the patient had CESI, the 
symptoms include urinary issues of neurogenic origin 
including loss of desire to void, altered urinary sensation 
and hesitancy with partial saddle anaesthesia.
It is documented in the literature that timely operative 
decompression for CES secondary to herniated lumbar 
disc can lead to improved outcomes in patients.7–9 In fact, 
delay or missed diagnosis of this condition incurs heavy 
litigation costs to the NHS at £3 36 000 (US $549 427) 
per case on average10 as reported to the Medical Defence 
Union in the UK.
rationale for the development of a Cos
An ‘outcome’ in relation to clinical research studies 
is defined to be a measurement or observation used to 
capture and assess the effect of treatment such as assess-
ment of the side effects (risk) or effectiveness (benefits).11
Before the systematic literature review a scoping review 
was undertaken.12 It was identified that there were no 
randomised controlled trials, many retrospective obser-
vational studies and few prospective studies reporting the 
clinical outcome of patients with CES. There is heteroge-
neity and inconsistency in the outcomes reported in the 
literature for CES. The outcomes reported in the litera-
ture have not been independently validated as important 
to key stakeholders.
There is no defined core outcome set (COS) in CES 
currently, and this protocol will describe the methods of 
how to develop it. A COS defines the minimum outcomes 
that should be consistently measured and reported in 
clinical trials in a specific area of healthcare.13 With this 
there will be greater reporting consistency and a reduc-
tion in outcome reporting bias in healthcare studies 
contributing to systematic reviews and meta-analysis14 
that can lead to informed healthcare decisions.
Initially, a systematic literature review and qualitative 
patient interviews will be conducted to document the 
outcomes for patients with CES after surgery. These 
outcomes will be combined and prioritised through two 
rounds of a Delphi process with key stakeholders and a 
consensus meeting to decide the COS. The COS would 
be published and used for future research studies and 
improving outcome reporting in CES.
The development of COSs has been done successfully 
in rheumatology with the Outcomes Measures in Rheu-
matoid Arthritis Clinical Trials group. This international 
collaboration was developed in the early 1990s involving 
patients in the development of COSs and has improved 
consistency of reported trials in this specialty.14 15 The 
Core Outcome Measures in Effectiveness Trials (COMET) 
initiative advocates the involvement of patients and 
currently holds a database of on-going COS developers16 
to minimise duplication and foster health service user 
engagement.13 17
scope of the Cos
We aim to identify ‘what’ outcomes of patients with CES 
are of concern to key stakeholders using transparent 
methodology. We are not intending to consider how these 
outcomes should be measured. The 11 minimum Core 
Outcome Set Standards for Development (COS-STAD) 
recommendations are addressed in this protocol18 
(table 1).
registration
The study is registered on the COMET database as study 
824 (http://www. comet- initiative. org/ studies/ details/ 
824? result= true).
MEthods And AnAlysIs
Development of the COS will be developed in four phases 
with their estimated time frames highlighted in the 
overall study timeline (figure 1). Timeframes includes 
the estimated duration for ethical approval, study recruit-
ment and analysis.
Phase 1: systematic literature review
Research question
What outcomes are reported in the medical literature 
after surgery for CES?
summary
The aim of the systematic literature review was to 
summarise the reporting standards of the clinical 
outcomes after surgery in patients with CES following 
the Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses guidelines.19 Most CES cases are 
due to lumbar disc herniation,20 which requires urgent 
surgical intervention. Study inclusion was limited to arti-
cles with patients who were surgically managed and whose 
outcomes were recorded.
The systematic literature review summarised the 
outcomes that had been mentioned in the literature and 
categorised them into a known taxonomy.21 About 1873 
articles were identified through the search strategy of 
which 61 met the inclusion criteria. Inclusion criteria 
specified details regarding the study design, diagnosis, 
procedure, publication date, language and the patient 
age. Where 737 outcomes were reported verbatim in the 
61 included articles. These were then categorised to 20 
higher order groupings called ‘outcome domains.’ The 
most commonly reported outcomes were bladder func-
tion (70.5%), motor function (63.9%) and sensation 
(50.8%). There was significant variation in the terms 
used for each outcome for example, bladder function 
outcome domain had 141 different terms. Significant 
heterogeneity was evident in the outcomes reported in 
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CES research studies. This highlighted a need for a COS 
in CES to be developed.22
Phase 2: qualitative interviews
Research question
What outcomes have CES patients experienced after 
surgery and how do they feel about the management 
before and after surgery?
MEthod
The objectives of the qualitative interviews with patients 
with CES are:
 ► To explore the patient experience of living with CES.
 ► To document what the patient describes as the most 
important outcomes they are experiencing.
 ► To determine what service improvements can be 
made to improve CES management and aftercare.
 ► To determine who should be the key stakeholders in 
the Delphi survey.
 ► Identify appropriate language to use for the Delphi 
survey.23
These interviews will be documented with audio 
recorded transcripts. The list of all potential outcomes 
from the systematic review and qualitative interviews will 
be placed into outcome domains by the research team to 
avoid repetition by qualitative method of content anal-
ysis.24 The qualitative interviews will be piloted with two 
patients with CES to establish if the interview structure 
and technique is clear, understandable and capable of 
answering the research questions. This would recognise 
any corrections that need to be made to the interview 
structure or technique. Inclusion and exclusion criteria 
are shown in table 2.
Participant selection
Adult patients for the qualitative interviews will be selected 
from those coded as having a diagnosis of CES in the 
medical records. There is an existing database of patients 
with CES who have been operated on and followed up by 
consultants, registrars or nurse specialists depending on 
the next available clinic. Adult patients will be 18 years or 
older who have had spinal surgery to remove the compres-
sive lesion at a single tertiary NHS institution over the 
past 10 years. The qualitative interviews will capture short 
and long-term outcomes that are deemed important to 
them. Duration of the recorded outcomes will be calcu-
lated since the initial operation for CES.
Stratified purposive sampling25 was chosen in which the 
aim is to select groups that display variation in particular 
characteristics so the subgroups can then be compared. 
Characteristics known to have an impact on the outcomes 
being investigated have been identified—severity of CES 
(CESI or CESR)4 then there is a subgroup about which 
little is known and whose circumstances and views need 
to be explored; short (≤2 years) or long term (>2 years 
and ≤10 years) since the operation (see table 3). This 
Table 1 Core Outcome Set Standards for Development recommendations
Domain
Standard
number Methodology Notes
Scope
specification
1 The research or practice setting in which the 
COS is to be applied.
Research studies that will inform clinical decision 
making.
2 The health condition(s) covered by the COS. All severities of cauda equina syndrome (CES).
3 The population(s) covered by the COS. Human adults aged 18 or above.
4 The intervention(s) covered by the COS. Clinical management of CES including surgery.
Stakeholders involved 5 Those who will use the COS in research. Clinical trialists in CES are healthcare 
professionals who manage patients with CES. 
They are included in standard 6.
6 Healthcare professionals with experience of 
patients with the condition.
This will include clinicians, experts and 
healthcare professionals involved in CES 
management.
7 Patients with the condition or their 
representatives.
Patients with a diagnosis of CES will be 
included.45
Consensus
Process
8 The initial list of outcomes considered both 
healthcare professionals and patients views.
Systematic literature review22 considered 
healthcare professional views. Qualitative 
interviews considered patient views.
9 A scoring process and consensus definition were 
described a priori.
Described in the ‘Scoring’ and ‘Analysis’ section 
of this protocol.
10 Criteria for including/dropping/adding outcomes 
were described a priori.
Described in the ‘Analysis’ section of this 
protocol.
11 Care was taken to avoid ambiguity of language 
used in the list of outcomes.
Plain language and clinical explanations 
available. These will be pilot tested with patients 
and healthcare professionals.
CES, cauda equina syndrome; COS, core outcome set.
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will produce four subcategories to populate. This is to 
prevent potential bias you may get from having many 
patients who presented with a severe clinical picture and 
poor outcomes being more forthcoming and vocal. All 
subcategories for the sampling frame will be deemed a 
priority. Half the participants would ideally be male and 
half would be female.
There is an existing database of 200 patients with 
contact details and clinical details of presentation and 
management, which will be updated up to the current 
date to exclude patients who are deceased. This should 
produce 50 patients per category. Due to reasons such 
as long travel distance from institution, not interested 
in participating it is anticipated that up to 10 patients 
may reply from each category, which would produce up 
to 40 patients in total. Options will be given to be inter-
viewed at home, via electronic media (Skype), over the 
phone or to attend the hospital in person. After informed 
consent, patients will be interviewed until ‘data satura-
tion’ is reached. The research team will decide when data 
saturation is reached. Data saturation is the point where 
increasing the sample size no longer contributes to new 
evidence26 moreover even large qualitative studies do not 
interview more than 50 people.27 Additional patients will 
be interviewed in the subcategories if one group has a 
better response rate until data saturation is achieved.
Sticking rigidly to a sample frame could be counter intu-
itive as one patient can be data rich during the interview 
as opposed to interviewing five patients where data is 
not rich. The aim is to collect rich data to allow in depth 
analysis.26 So, although the sampling frame may serve as 
a guide it will not be used to start restricting participants 
especially at the initial stages of doing the qualitative 
interviews until data saturation is achieved.
An information leaflet and stamped addressed envelope 
to return the response slip will be sent to participants with 
a consent form. Patients will have 3 weeks to ‘opt-out’ of 
the study by returning a response slip, through email or 
telephone with the research team. After this, the partici-
pants will receive a phone call from the research team to 
confirm interest for participating in the study, to answer 
any further questions and to arrange a time and location 
for the interview.
Figure 1 The overall study timeline.
Table 2 Inclusion and exclusion criteria for qualitative 
interviews
Inclusion criteria Exclusion criteria
Adult patients Adults unable to consent for 
research
Diagnosis of cauda equina 
syndrome (CES)
Patient underwent a surgical 
procedure for CES
Less than 10 years since the 
surgical procedure
Ability to converse in English 
and to consent for research
Table 3 Sampling frame with suggested quotas
Cauda equina 
syndrome 
incomplete
Cauda equina 
syndrome with 
retention
Short term since the 
operation (≤2 years)
10 participants 10 participants
Long term since the 
operation (>2 years and 
≤10 years)
10 participants 10 participants
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Interview format and analysis
A semistructured interview format will be used as per our 
topic guide (online supplementary file 1). Qualitative 
semistructured interviews were chosen over question-
naires and focus groups as it was believed that patient 
opinions over sensitive subject matter such as bowel, 
bladder and sexual function would be better elicited in 
a private one-to-one interview and they were less likely to 
inhibit their contribution.26 In addition, one-to-one inter-
views are more accessible for potential participants and 
for patients with mobility restrictions.
Informed consent will be obtained prior to the interview 
where anonymity and confidentiality will be expressed. 
The consent will also request the patient’s permission for 
their general practitioner (GP) to be informed of their 
involvement in the study. This is so that if there is any 
distress during the patient interviews, which requires 
medical management they can be referred to their GP. 
Open-ended non-leading questions on their diagnosis, 
management postoperatively in hospital and management 
in the community will be asked allowing the participant to 
describe their experiences without unnecessary interrup-
tion.27 Discussion will be directed towards outcomes of 
importance to the patient as seen in the topic guide. The 
interviewer will not discuss their own opinions about CES, 
and if these are asked they will be answered at the end of 
the interview session. Reflexivity is an important concept 
during qualitative research for striving towards objectivity 
and neutrality,26 and the analysis of the interviews will 
consider if bias from the interviewer’s own beliefs may 
have crept in. It is anticipated that the interview will last 
for 45 min to an hour at each sitting to prevent the partic-
ipant feeling fatigued. The same interviewer (NS) will be 
used for all the patient interviews. All interviewees will be 
made aware that the interviewer is a doctor not involved 
in their on-going care. A sample of the transcripts will be 
reviewed by a supervisor not involved in the qualitative 
interviews to confirm that they were undertaken in a satis-
factory manner.
Initially, the transcripts will be reviewed to start iden-
tifying which outcomes are important to the patients 
by labelling the data using NVivo qualitative data anal-
ysis software V.10. A pragmatic approach will be taken 
by using thematic analysis as per the Braun and Clarke 
method.28 It is a pattern-based qualitative method like 
grounded theory29 and interpretative phenomenological 
analysis30 but is not linked to a specific theoretical frame-
work. This method will allow summarisation of the key 
outcomes of each individual transcript and overall themes 
while retaining the context and language in which it was 
expressed.26 The qualitative interviews will be reported as 
outlined by the Consolidated criteria for Reporting Qual-
itative research (COREQ); a 32-item checklist.31
Phase 3: the delphi survey
The outcomes from the systematic literature review and 
qualitative interviews will create a long list.11 This will be 
condensed by grouping similar outcomes into domains 
and conforming with the taxonomy used in the systematic 
literature review.21 22 This will be reviewed and agreed by 
the study team and pilot tested with the key stakeholders 
before the Delphi survey is distributed.
research question
Which outcomes do patients and healthcare professionals 
think should be included in a COS for patients with CES?
MEthod
All patients with CES will be invited to participate in the 
Delphi survey regardless of whether they had had surgery 
or not. Although there are a minority of participants in 
the category of non-operative management of CES32 it 
was decided by the study team that including them will 
be an opportunity to consider their input and maximise 
recruitment. The Delphi will be done by healthcare 
professionals and patients.
To achieve a priority list, we will use the ‘modified’ 
Delphi method33 as opposed to the ‘traditional’ Delphi 
method.34 Traditionally in a Delphi survey patients are 
asked open questions in the first round of the Delphi 
and the answers would constitute the outcomes rated in 
the second round. In the ‘modified’ Delphi, which will 
be used in this study, rating the outcomes will take place 
over two rounds. A list of outcomes previously attained 
from the systematic literature review and qualitative inter-
views will be presented in the first round of the Delphi.33 
Patients can also suggest outcomes that have not been 
mentioned in the first round, but these will not be scored. 
They will be considered for inclusion into the second 
round of the Delphi if, as judged by the CES study team, 
the outcome does not reflect or is not similar to another 
outcome already listed. The CES study team includes a 
patient representative.
The level of anonymity will be ‘fully anonymised’35 so 
participants do not know the identities of other indi-
viduals in the group and they will not know the specific 
answers other individuals give. In round 2 of the Delphi, 
participants will know the group responses from the 
patient group and the healthcare professional group. 
Individual participants can decide to keep their original 
rating or to change their rating in the next round. This 
will lead to the group converging on a consensus opinion 
over the course of these two rounds.35
Inclusion criteria
Participants will be recruited from two key stakeholder 
groups: patients and healthcare professionals. All partic-
ipants will be adults over 18 years of age and able to 
complete an online survey in the English language.
Patients
Participants who have had an operation for CES.
Healthcare professionals
All members of the clinical team involved in directly 
caring for a patient with CES such as:
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 ► Spinal surgeons
 ► Spinal specialist nurses
 ► Neurorehabilitation doctors
sampling and recruitment
Patients
At the main site, the clinical care team have a pre-ex-
isting database of patients with CES they have clinically 
managed. The clinical care team will send an invitation 
letter to the home address of these patients. There will 
be no follow-up calls or further correspondence. It is the 
patient’s decision if they wish to be involved and the invi-
tation will contain details of the website address patients 
can access if they wish to find out more details regarding 
the study. Online patient groups for CES will be contacted 
internationally. A named contact for each group will act 
as the liaison member to circulate the participant invi-
tation email and poster. This may include the patient 
groups sharing the recruitment details on social media.
Healthcare professionals
The main study site has spinal multidisciplinary team 
meetings held weekly. The coordinator has a preset 
mailing list that goes to healthcare professionals involved 
in the meeting. This will be used to send the partici-
pant invitation email. The membership of national and 
international associations will be contacted and invited 
to participate. They include different healthcare profes-
sionals in their membership categories. Some examples 
are listed below:
 ► Society of British Neurological Surgeons
 ► British Association of Spine Surgeons
 ► World Federation of Neurorehabilitation
 ► Spinal Injuries Association
Known contacts of the CES study group will be contacted 
and invited to participate. Snowballing sampling will be 
used to increase the sample size. The participant invita-
tion email/letter will be the first contact for healthcare 
professionals and patients, which is a short introduction 
and summary of the study. If they are interested further 
the participant can proceed to the registration website for 
further details and obtain a copy of the participant infor-
mation leaflet.
sample size
There are no strict recommendations for the number 
of participants (patients and healthcare professionals) 
required in a Delphi study to gain consensus.35 In general, 
having more participants will increase the reliability of 
the group judgement.36 A pragmatic approach to sample 
size will be taken and all individuals who meet the inclu-
sion criteria as identified above will be invited to partici-
pate. The recruitment phase will be 2 months before the 
first round of the Delphi survey is released. Documenta-
tion of the organisations who distribute the Delphi invi-
tation from each stakeholder group will be recorded. No 
further participants will be invited after the first round of 
the Delphi.
Consent
Consent will be implicit by the participant (patients and 
healthcare professionals) registering their name and 
email address to take part in the Delphi survey via the 
website.
Questionnaires
The questionnaire is constructed and delivered in an 
online format using the DelphiManager software devel-
oped by the COMET initiative. Before starting the ques-
tionnaire, the participant will be asked to clarify which 
of the two stakeholder groups they belong to. For each 
stakeholder group, specific information will be collected:
 ► Patients—age, gender, location, surgery for CES— 
yes/no, years since surgery for CES, employed— full 
time/employed part time/unemployed.
 ► Healthcare professionals—practising field (spinal 
surgeon, specialist nurse, neurorehabilitation etc), 
years in practice, location, gender.
Following confirmation of their eligibility to participate 
in the study, participants will be sent an on-line link to 
access the first round of the Delphi process. Instructions 
of how to complete the questionnaire will be included 
at the beginning of each round. Only participants who 
respond to the first round of the Delphi will be invited to 
participate in second round taking the assumption that if 
they had not participated in the first round they would be 
unwilling to participate in the second round. Data will be 
collected over at least a 4-week period for each round of 
the Delphi process. Participants who have not completed 
the survey will be sent reminders via email when they have 
2 weeks, 1 week and 48 hours remaining for completion of 
the survey. Participants who have not completed the ques-
tionnaire within 4 weeks of the start will be deemed not to 
have completed that round of the Delphi. The language 
used by patients in the qualitative interviews will be used 
to help term the outcomes for the Delphi. Plain language 
summaries by the COMET Patient Participation, Involve-
ment and Engagement group was used to develop the 
Delphi information sheet. The Delphi will be piloted with 
two participants from each stakeholder group to high-
light any issues with understanding or validity.
scoring
For an outcome to be included in the COS, there must 
be a majority agreement of the critical importance of the 
outcome and minority agreement that the outcome is not 
important.37 This is in par with the Grading of Recommen-
dations Assessment, Development and Evaluation working 
group recommendations (http://www. gradeworking-
group. org;.38 39 At the beginning of the Delphi, partici-
pants will be reminded the importance of completing the 
entire Delphi process. Round one of the Delphi study, we 
will ask participants to rate each outcome using a nine 
point Likert scale. This scoring system was chosen after 
previous studies and expert databases showed it differen-
tiates the most between questionnaire items.16 35 From 7 
to 9 indicates critical importance. Where 4 to 6 represents 
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outcomes that are important but not critical while 1 to 3 
are deemed to be of limited importance. All outcomes 
will be carried through to second round with anonymised 
feedback of first round scores from the patient group 
and from the healthcare professional group displayed 
for each outcome. The feedback will show the cumulated 
scores from each stakeholder group for each outcome, 
and the participant will be asked to rate the outcomes 
again using the same nine point Likert scale. If they 
change their score on the second round they will have the 
opportunity to explain their reasoning for this. Outcomes 
which have been suggested in round 1 by the participants 
and deemed appropriate by the study group will then be 
entered in for rating in the second round by key stake-
holders. After the final Delphi round, there will be a list 
developed from all stakeholder groups, which will be 
submitted to a face to face consensus meeting of key stake-
holders to discuss what outcomes that should be finally 
included in the COS. All participants who had completed 
both rounds of the Delphi survey will be eligible for invi-
tation to the consensus meeting. A trained independent 
facilitator would chair this meeting.
Analysis
Consensus that an outcome should be included in the 
COS is defined as 70% or more scoring it as 7 to 9 and 
fewer than 15% scoring it as 1 to 3, which is has been seen 
to be successful with the development of other COSs40 41 
(table 4). This will be done for each stakeholder group. 
Results at the multiple rounds of the Delphi process and 
consensus meeting will be documented to include the 
number of participants invited, number completing the 
section, measure of each group response to an outcome 
leading to a comprehensive list of all outcomes that 
should be included in the COS CES.
Attrition
It is expected that some participants will drop out after 
each round of the Delphi. Each participant will be given a 
unique participant number when they complete the first 
round of the Delphi, which will allow calculation of the 
attrition rates between rounds. This will allow identifica-
tion of participants who have completed all rounds and 
see if there is any difference bias between those partici-
pants who complete the process. Mean round 1 scores for 
the participants who completed round 1 and round 2 will 
be compared with those that dropped out after round 1.
Phase 4: consensus meeting
All participants registering for the Delphi survey will 
be asked if they would be happy to attend a face to face 
consensus meeting involving patients and healthcare 
professionals. They will need to complete both rounds of 
the Delphi survey to be eligible to attend. This would be 
set up as a tick box on the registration page for the online 
Delphi.
Forty participants will be invited to the consensus 
meeting. This will include 20 healthcare professionals and 
20 patients. Out of the 40 participants; 30 will be from the 
UK and 10 will be international. Standard travel expenses 
and hotel accommodation will be reimbursed or provided. 
Tenof the participants at the consensus meeting will be 
invited before the Delphi survey is released to attend the 
consensus meeting but on the premise, that both rounds 
of the Delphi are completed. This is to make sure there is 
representation at the consensus meeting from key stake-
holder organisations closely involved with patients with 
CES, research or management. Thirty participants at the 
consensus meeting will be those who have completed 
both rounds of the Delphi and ticked their interest to 
attend the consensus meeting during registration.
In the development of a breast reconstruction COS 
patients and professionals were recruited in a 2:1 ratio so 
that patients’ views were represented preferentially as the 
procedure is a patient selected optional intervention.42 In 
our study, clinical intervention for CES is performed as 
an emergency so it was deemed appropriate by the study 
team to have a 1:1 ratio of patients and healthcare profes-
sionals. This is to maximise the number of participants 
involved to help achieve consensus. In addition, the COS 
should reflect all key stakeholders input equally. If there 
is an overwhelming response with more than 40 partici-
pants interested in attending the consensus meeting the 
study team will apply stratified purposive sampling. On 
the day of the consensus meeting, informed consent will 
be obtained from the patient participants.
Outcomes categorised as ‘consensus in’ across both 
stakeholder groups from the Delphi survey (table 4) will 
be included in the final COS. Outcomes categorised as 
‘consensus out’ across both stakeholder groups from the 
Delphi survey will be excluded from the final COS. Results 
of the Delphi survey will be discussed at the consensus 
meeting, and the main discussion will be regarding the 
outcomes deemed as achieving ‘no consensus’ in the 
Table 4 Definitions of a consensus
Classification 
of consensus Description Definition
In Consensus that outcome should be included in the 
core outcome set.
70% or more participants scoring as 7 to 9 
AND <15% participants scoring as 1 to 3 in both 
stakeholder groups.
Out Consensus that outcome should not be included in 
the core outcome set.
50% or less participants scoring 7 to 9 in both 
stakeholder groups.
No consensus Uncertainty about importance of outcome. Anything else.
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Delphi survey. Participants at the meeting will vote on 
these outcomes. The same criteria for consensus used in 
the Delphi survey (table 4) will be used in the consensus 
meeting. All outcomes that reach ‘consensus in’ will be 
included in the COS. All outcomes in the ‘consensus out’ 
or ‘no consensus’ category after voting in the consensus 
meeting will not be included in the COS. If there is no 
agreed final COS at the end of the first meeting subse-
quent meetings will be arranged for this to happen. 
The participants who had completed both rounds of 
the Delphi survey would be invited to attend another 
consensus meeting if required.
PAtIEnt InvolvEMEnt
Patients will be involved in the design, review and recruit-
ment of the study. The scope of the research question will 
be decided with the study team that includes two research 
partners who are patients with CES. The qualitative inter-
views will be trailed with the patient research partners, 
and the topic guide will be reviewed by them. Pilot testing 
of the Delphi survey will be done by the patient research 
partners who will be asked to review the patient expla-
nations of the outcomes and the questions on the regis-
tration page. Patients will be involved in the recruitment 
stage of the Delphi as they will be requested via social 
media to forward the website link for the Delphi survey to 
any relevant known contacts.
EthICs And dIssEMInAtIon
We intend to publish the results of the COS for patients 
with CES in an open access journal. It will also be made 
available through the CES patient charity websites. 
Results will be disseminated through international and 
national presentations. The next step would be to identify 
the appropriate measurement instrument for each of the 
outcomes in the COS.43 COSs are developed in a number 
of clinical areas and their use is advocated in the UK by 
the National Institute for Health Research (NIHR) Health 
Technology Assessment (HTA), Cochrane Reviews of the 
effects of Healthcare intervention44 and by WHO hand-
book for guideline development.17 The NIHR HTA has 
added this statement to their application form, “Where 
established core outcomes exist they should be included 
among the list of outcomes unless there is a good reason 
to do otherwise.’ By developing the CES COS, we intend 
to reduce outcome reporting bias, heterogeneity and 
improve the quality of research studies in CES. This will 
allow us to synthesise the data and make more robust 
evidence-based decisions regarding the management of 
CES.
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